SOPHiA GENETICS SA (NASDAQ:SOPH) Sees Significant Growth in Short Interest

SOPHiA GENETICS SA (NASDAQ:SOPH - Get Free Report) was the target of a large increase in short interest in February. As of February 15th, there was short interest totalling 37,600 shares, an increase of 89.9% from the January 31st total of 19,800 shares. Currently, 0.1% of the company's stock are short sold. Based on an average trading volume of 69,500 shares, the days-to-cover ratio is presently 0.5 days.

SOPHiA GENETICS Stock Up 0.3 %

Shares of SOPH traded up $0.01 during midday trading on Wednesday, reaching $3.11. 45,986 shares of the company were exchanged, compared to its average volume of 70,057. The company has a current ratio of 3.80, a quick ratio of 3.59 and a debt-to-equity ratio of 0.12. SOPHiA GENETICS has a 1-year low of $2.70 and a 1-year high of $6.28. The stock has a 50-day moving average price of $3.58 and a 200-day moving average price of $3.56. The company has a market cap of $203.32 million, a price-to-earnings ratio of -2.85 and a beta of 1.03.

SOPHiA GENETICS (NASDAQ:SOPH - Get Free Report) last announced its quarterly earnings data on Tuesday, March 4th. The company reported ($0.23) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.23). The firm had revenue of $17.73 million for the quarter, compared to analysts' expectations of $17.71 million. SOPHiA GENETICS had a negative return on equity of 55.06% and a negative net margin of 110.71%. Research analysts expect that SOPHiA GENETICS will post -0.96 earnings per share for the current year.

Remove Ads

Analysts Set New Price Targets

Separately, Craig Hallum started coverage on SOPHiA GENETICS in a research report on Wednesday, December 18th. They issued a "buy" rating and a $11.00 target price for the company. One research analyst has rated the stock with a hold rating and four have given a buy rating to the company's stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $7.40.

Hedge Funds Weigh In On SOPHiA GENETICS

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Dimensional Fund Advisors LP lifted its position in shares of SOPHiA GENETICS by 23.5% during the 4th quarter. Dimensional Fund Advisors LP now owns 21,619 shares of the company's stock valued at $68,000 after acquiring an additional 4,115 shares during the last quarter. Silverberg Bernstein Capital Management LLC acquired a new stake in shares of SOPHiA GENETICS in the fourth quarter valued at about $70,000. Green Alpha Advisors LLC grew its position in shares of SOPHiA GENETICS by 119.3% in the fourth quarter. Green Alpha Advisors LLC now owns 47,216 shares of the company's stock valued at $145,000 after purchasing an additional 25,686 shares during the last quarter. Federated Hermes Inc. grew its position in shares of SOPHiA GENETICS by 40.5% in the fourth quarter. Federated Hermes Inc. now owns 100,000 shares of the company's stock valued at $312,000 after purchasing an additional 28,819 shares during the last quarter. Finally, Millennium Management LLC lifted its stake in shares of SOPHiA GENETICS by 6.5% in the fourth quarter. Millennium Management LLC now owns 698,634 shares of the company's stock valued at $2,180,000 after buying an additional 42,689 shares during the period. 31.59% of the stock is owned by institutional investors.

SOPHiA GENETICS Company Profile

SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. The company offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific.